Skip to content
VuFind
  • Your Account
  • Log Out
  • Login
  • Language
    • English
    • Español
    • Français
Advanced
  • Corrigendum: Safety of Semaglu...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Bookmark
  • Permanent link
Corrigendum: Safety of Semaglutide
QR Code

Corrigendum: Safety of Semaglutide

Saved in:
Bibliographic Details
Main Authors: Mark M. Smits, Daniël H. Van Raalte
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
glucagon-like peptide-1 receptor agonist (GLP-1RA)
oral
subcutaneous
semaglutide
type 2 diabetes
safety
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Online Access:https://doaj.org/article/1d6095bb78274de5a98922ae3f3ed6df
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Internet

https://doaj.org/article/1d6095bb78274de5a98922ae3f3ed6df

Similar Items

  • Safety of Semaglutide
    by: Mark M. Smits, et al.
    Published: (2021)
  • Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
    by: Pearson S, et al.
    Published: (2019)
  • Efficacy and safety of dulaglutide in patients with absolute insulin deficiency
    by: Kutoh Eiji, et al.
    Published: (2019)
  • Unexpected bleeding after Exenatide treatment: a causative relationship or a coincidence?
    by: Khoury Johad, et al.
    Published: (2018)
  • Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    by: Hua-Xing Huang, et al.
    Published: (2021)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs
Loading...